<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Pacheco-López G</dc:creator>
  <dc:creator>Riether C</dc:creator>
  <dc:creator>Doenlen R</dc:creator>
  <dc:creator>Engler H</dc:creator>
  <dc:creator>Niemi MB</dc:creator>
  <dc:creator>Engler A</dc:creator>
  <dc:creator>Kavelaars A</dc:creator>
  <dc:creator>Heijnen CJ</dc:creator>
  <dc:creator>Schedlowski M</dc:creator>
  <dc:date>2009</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Pavlovian conditioning is one of the major neurobiological mechanisms of placebo effects, potentially influencing the course of specific diseases and the response to a pharmacological therapy, such as immunosuppression. In our study with behaviorally conditioned rats, a relevant taste (0.2% saccharin) preceded the application of the immunosuppressive drug cyclosporin A (CsA), a specific calcineurin (CaN) inhibitor. Our results demonstrate that through pavlovian conditioning the particular pharmacological properties of CsA can be transferred to a neutral taste, i.e., CaN activity was inhibited in splenocytes from conditioned rats after reexposure to the gustatory stimulus. Concomitant immune consequences were observed on ex vivo mitogenic challenge (anti-CD3). Particularly, Th1-cytokine, but not Th2-cytokine, production and cell proliferation were impeded. Appropriate pharmacological and behavioral controls certify that all these changes in T-lymphocyte reactivity are attributable to mere taste reexposure. Furthermore, the underlying sympathetic-lymphocyte interaction was revealed modeling the conditioned response in vitro. CaN activity in CD4(+) T lymphocytes is reduced by beta-adrenergic stimulation (terbutaline), with these effects antagonized by the beta-adrenoreceptor antagonist nadolol. In summary, CaN was identified as the intracellular target for inducing conditioned immunosuppression by CsA, contributing to our understanding of the intracellular mechanisms behind "learned placebo effects."</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/267472</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1096/fj.08-115683</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/19103649</dc:relation>
  <dc:source>FASEB journal : official publication of the Federation of American Societies for Experimental Biology. - 2009</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Calcineurin Inhibitors</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Cell Proliferation</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cells, Cultured</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Conditioning, Classical</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cyclosporine</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Immunosuppressive Agents</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Rats, Inbred Strains</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Saccharin</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Spleen</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Sweetening Agents</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">T-Lymphocyte Subsets</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">T-Lymphocytes</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Taste</dc:subject>
  <dc:title xmlns:ns17="xml" ns17:lang="en">Calcineurin inhibition in splenocytes induced by pavlovian conditioning.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
